Curaleaf Holdings Inc. (CURA) - Net Assets

Latest as of September 2025: CA$886.23 Million CAD ≈ $641.09 Million USD

Based on the latest financial reports, Curaleaf Holdings Inc. (CURA) has net assets worth CA$886.23 Million CAD (≈ $641.09 Million USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CA$2.88 Billion ≈ $2.09 Billion USD) and total liabilities (CA$2.00 Billion ≈ $1.44 Billion USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check how resilient are Curaleaf Holdings Inc.'s assets to evaluate the company's liquid asset resilience ratio.

Key Net Assets Metrics

Metric	Value
Current Net Assets	CA$886.23 Million
% of Total Assets	30.74%
Annual Growth Rate	159.06%
5-Year Change	-27.82%
10-Year Change	694457.49%
Growth Volatility	86826.54

Curaleaf Holdings Inc. - Net Assets Trend (2014–2024)

This chart illustrates how Curaleaf Holdings Inc.'s net assets have evolved over time, based on quarterly financial data. Also explore Curaleaf Holdings Inc. (CURA) total assets for the complete picture of this company's asset base.

Annual Net Assets for Curaleaf Holdings Inc. (2014–2024)

The table below shows the annual net assets of Curaleaf Holdings Inc. from 2014 to 2024. For live valuation and market cap data, see CURA market cap overview.

Year	Net Assets	Change
2024-12-31	CA$993.39 Million ≈ $718.61 Million	-15.19%
2023-12-31	CA$1.17 Billion ≈ $847.29 Million	-16.39%
2022-12-31	CA$1.40 Billion ≈ $1.01 Billion	-15.87%
2021-12-31	CA$1.67 Billion ≈ $1.20 Billion	+20.99%
2020-12-31	CA$1.38 Billion ≈ $995.53 Million	+241.11%
2019-12-31	CA$403.45 Million ≈ $291.85 Million	-7.39%
2018-12-31	CA$435.64 Million ≈ $315.14 Million	+315.83%
2017-12-31	CA$104.77 Million ≈ $75.79 Million	+289482.07%
2016-12-31	CA$36.18K ≈ $26.17K	-74.71%
2015-12-31	CA$143.03K ≈ $103.46K	+96.30%
2014-12-31	CA$72.86K ≈ $52.71K	--

Equity Component Analysis

This analysis shows how different components contribute to Curaleaf Holdings Inc.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have decreased by 135612798325.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2024)

Component	Amount	Percentage
Common Stock	CA$2.24 Billion	259.80%
Other Comprehensive Income	CA$-20.08 Million	-2.33%
Total Equity	CA$861.21 Million	100.00%

Curaleaf Holdings Inc. Competitors by Market Cap

The table below lists competitors of Curaleaf Holdings Inc. ranked by their market capitalization.

Company	Market Cap
TMC the metals company Inc NASDAQ:TMC	$2.23 Billion
Sino-Platinum Metals Co Ltd SHG:600459	$2.23 Billion
KPIT Technologies Limited NSE:KPITTECH	$2.23 Billion
Calumet Specialty Products Partners NASDAQ:CLMT	$2.23 Billion
Kaiser Aluminum Corporation NASDAQ:KALU	$2.23 Billion
Alupar Investimento SA SA:ALUP11	$2.23 Billion
Carl Zeiss Meditec AG F:AFX	$2.23 Billion
BW LPG Limited NYSE:BWLP	$2.23 Billion

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Curaleaf Holdings Inc.'s equity between the two most recent reporting periods.

Equity Growth Insights

From 2023 to 2024, total equity changed from 1,050,642,000 to 861,214,000, a change of -189,428,000 (-18.0%).
Net loss of 215,423,000 reduced equity.
Share repurchases of 156,000 reduced equity.
Other comprehensive income decreased equity by 8,205,000.
Other factors increased equity by 34,356,000.

Equity Change Factors (2023 to 2024)

Factor	Impact	Contribution
Net Income	CA$-215.42 Million	-25.01%
Share Repurchases	CA$156.00K	-0.02%
Other Comprehensive Income	CA$-8.21 Million	-0.95%
Other Changes	CA$34.36 Million	+3.99%
Total Change	CA$-	-18.03%

Book Value vs Market Value Analysis

This analysis compares Curaleaf Holdings Inc.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 3.96x
The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
The price-to-book ratio has decreased from 46.62x to 3.96x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2014-12-31	CA$0.10	CA$4.59	x
2015-12-31	CA$0.17	CA$4.59	x
2016-12-31	CA$0.03	CA$4.59	x
2017-12-31	CA$0.33	CA$4.59	x
2018-12-31	CA$1.11	CA$4.59	x
2019-12-31	CA$0.88	CA$4.59	x
2020-12-31	CA$2.47	CA$4.59	x
2021-12-31	CA$2.21	CA$4.59	x
2022-12-31	CA$1.80	CA$4.59	x
2023-12-31	CA$1.45	CA$4.59	x
2024-12-31	CA$1.16	CA$4.59	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Curaleaf Holdings Inc. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): -25.01%
The company may be facing challenges in efficiently utilizing shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: -16.04%
• Asset Turnover: 0.46x
• Equity Multiplier: 3.42x
Recent ROE (-25.01%) is above the historical average (-57.35%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2014	-63.16%	0.00%	0.00x	1.13x	CA$-53.30K
2015	-112.42%	0.00%	0.00x	1.06x	CA$-175.08K
2016	-326.67%	-3.19%	77.76x	1.32x	CA$-121.80K
2017	-4.79%	-26.12%	0.13x	1.44x	CA$-15.58 Million
2018	-14.04%	-80.30%	0.14x	1.29x	CA$-105.95 Million
2019	-17.09%	-31.60%	0.30x	1.80x	CA$-110.72 Million
2020	-4.45%	-9.79%	0.26x	1.73x	CA$-199.01 Million
2021	-7.06%	-9.02%	0.39x	2.01x	CA$-263.74 Million
2022	-29.45%	-28.21%	0.39x	2.67x	CA$-504.90 Million
2023	-26.76%	-20.88%	0.43x	2.95x	CA$-386.26 Million
2024	-25.01%	-16.04%	0.46x	3.42x	CA$-301.54 Million

Industry Comparison

This section compares Curaleaf Holdings Inc.'s net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.

Industry Context

Industry: Drug Manufacturers - Specialty & Generic
Average net assets among peers: $739,937,582
Average return on equity (ROE) among peers: -40.74%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
Curaleaf Holdings Inc. (CURA)	CA$886.23 Million	-63.16%	2.25x	$2.23 Billion
Aurora Cannabis Inc (ACB)	$601.87 Million	-11.52%	0.39x	$193.63 Million
Amotiv Limited (AOV)	$915.11 Million	1.59%	0.43x	$553.67 Million
Aequus Pharmaceuticals Inc (AQS)	$-4.29 Million	0.00%	0.00x	$479.73K
Avicanna Inc (AVCN)	$841.07K	-309.08%	1.52x	$13.17 Million
Avant Brands Inc (AVNT)	$-490.96K	0.00%	0.00x	$4.13 Million
Bausch Health Companies Inc (BHC)	$5.23 Billion	-16.55%	4.34x	$2.06 Billion
CanadaBis Capital Inc (CANB)	$150.00K	0.00%	0.00x	$1.53 Million
Cannabist Company Holdings Inc (CBST)	$550.08 Million	-25.79%	1.50x	$12.59 Million
Cipher Pharmaceuticals Inc (CPH)	$80.52 Million	25.31%	0.07x	$326.62 Million
Cardiol Therapeutics Inc Class A (CRDL)	$22.27 Million	-71.36%	0.11x	$148.65 Million

About Curaleaf Holdings Inc.

TO:CURA Canada Drug Manufacturers - Specialty & Generic

Market Cap

$2.23 Billion

CA$3.09 Billion CAD

Market Cap Rank

#5867 Global

#189 in Canada

Share Price

CA$4.59

Change (1 day)

-3.77%

52-Week Range

CA$1.07 - CA$6.49

All Time High

CA$18.62